Recent Updates
Recently added Catalysts

Sonida Senior Living, Inc.

SNDAFDA catalysts, PDUFA dates & pipeline intelligence
$33.68
▲ +0.2 · +0.58%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full SNDA financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $24.9552W HIGH $44.38
Volume
56.24 K
Value Traded
34.04 M
Short % Float
7.47%
Days to Cover
8.8
-7.53%Week
-12.99%1 Month
-17.43%3 Month
-5.63%6 Month

Cash Data

Unlock SNDA cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.61 B
EPS (TTM)
-2.55
P/E Ratio
-
Ent. Value
3.15 B
Total Shares
48.05 M
Float Shares
47.24 M
Insiders
1.69%
Institutions
83.04%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every SNDA catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

SNDA Catalyst Timeline

Dated clinical, regulatory and corporate events for Sonida Senior Living, Inc.

Catalyst Timeline

Dated clinical, regulatory & corporate events for Sonida Senior Living, Inc.

1Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage

Event history 1

●Quarterly UpdateCorporate
Q2 2026 earnings conference call and webcast
Unlock the full SNDA catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How SNDA actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all SNDA historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Sonida Senior Living, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every SNDA program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every SNDA trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock SNDA insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Simanovsky MichaelDirector, 10% OwnerSell -97,581 100,373 held$38.42 09/01/2026
Unlock the full SNDA insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in SNDA for Q2 2026.
Unlock every fund holding SNDA
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in SNDA
Shares held by hedge funds each quarter, and who bought or sold.

SNDA Institutional Ownership Trends

SNDA Short Interest

Shares sold short, counted twice a month.

7.47%
Short % of Float
of tradable shares sold short
3.5M
Shares Sold Short
-0.6% vs prior count
8.8 High
Days to Cover
trading days of normal volume to buy every short share back
403.2K
Avg Daily Volume
the average used for days to cover
Unlock SNDA short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock SNDA option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live SNDA option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock SNDA options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How SNDA ranks across every disease it competes in

Competitive Position is a premium feature
See how SNDA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

SNDA News

-SNDA
Oct 22, 2026
SNDAConferences/Events
▲ +0.6%today

Sonida Senior Living Announces Third Quarter Earnings Release Date and Conference Call

Sonida Senior Living will announce its third quarter 2026 earnings on November 5, 2026. The company plans to host a conference call at 11:00 a.m. Eastern Time to discuss its financial and operational results. This engagement aims to provide investors with a comprehensive overview of the company's performance.

Read more →
-SNDA
Aug 10, 2026
SNDAGeneral

Sonida Senior Living Announces Second Quarter 2026 Results

Sonida Senior Living, Inc. reported positive results for the second quarter of 2026, highlighting a 240 basis point increase in occupancy within its Same-Store Portfolio, reaching 87.8%. The company attributes this growth to the strengthening of its operating platform and effective execution of its growth strategy.

Read more →
-SNDA
Aug 3, 2026
SNDAConferences/Events

Sonida Senior Living Announces Second Quarter Earnings Release Date and Conference Call

Sonida Senior Living, Inc. announced its second quarter 2026 earnings release date, set for August 10, 2026, before market opening. Following the release, the company will host a conference call at 11:00 a.m. Eastern Time to discuss its financial performance and operating results. This event reflects Sonida's commitment to keeping stakeholders informed.

Read more →
-SNDA
Jun 1, 2026
SNDAGeneral
▼ -7.4%on this news

Sonida Senior Living Appoints Anton Nikodemus as Chief Operating Officer

Sonida Senior Living has appointed Anton Nikodemus as its new Chief Operating Officer. This leadership change aims to enhance the company's operational strategies and overall performance. The announcement reflects Sonida's commitment to strengthening its management team.

Read more →
-SNDA
May 13, 2026
SNDAGeneral

FINANCIAL STATEMENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES Page Report of Independent Registered Public Accounting Firm (PCAOB ID 238) 2 Consolidated Balance Sheets 4

CNL Healthcare Properties, Inc. released its consolidated financial statements for the years ending December 31, 2025 and 2024. The audit was conducted by PricewaterhouseCoopers LLP, indicating an independent review of the company's finances. The statements show an increase in rental income but also highlight a net loss attributed to operating expenses exceeding revenues. Additionally, the carrying value of real estate investment properties has decreased from the previous year, signaling potential concerns regarding asset performance.

Read more →
-SNDA
May 11, 2026
SNDAGeneral

Sonida Senior Living Announces First Quarter 2026 Results

Sonida Senior Living announced its financial results for the first quarter of 2026. The article provides insights into the company's performance, but lacks specific details or highlights. Overall, the announcement appears neutral without significant positive or negative developments.

Read more →
-SNDA
Apr 28, 2026
SNDAGeneral

Sonida Senior Living Publishes Letter to Shareholders in Connection with 2026 Annual Meeting

Sonida Senior Living has filed definitive proxy materials for its 2026 Annual Meeting, highlighting its strategic priorities and capital allocation plans. The company is transitioning into Phase 3, focusing on operational momentum and capital deployment to create long-term shareholder value. Management emphasizes a decentralized leadership model and performance-based compensation to enhance operational excellence.

Read more →
-SNDA
Apr 23, 2026
SNDAConferences/Events

Sonida Senior Living to Participate at Upcoming Investor Conferences in May

Sonida Senior Living, Inc. announced its participation in several investor conferences in May 2026. CEO Brandon Ribar will engage in panel discussions at the Wells Fargo and BMO conferences, along with a fireside chat at the RBC Capital Markets conference. The events aim to enhance investor relations and showcase the company's leadership in senior housing.

Read more →
-SNDA
Mar 11, 2026
SNDAGeneral
▼ -9.3%on this news

Sonida Senior Living, Inc. Announces Fourth Quarter and Full Year 2025 Results

Sonida Senior Living, Inc. reported significant financial growth for the fourth quarter and full year of 2025, achieving a 22% expansion in total portfolio NOI. The successful acquisition of CNL Healthcare Properties marked a pivotal moment for the company, positioning it among the largest senior housing asset owners in the U.S. Despite these positive achievements, the company faced a net loss increase due to transaction costs related to the merger. Looking ahead, Sonida expresses confidence in driving further growth through its integrated owner-operator model.

Read more →
-SNDA
Mar 11, 2026
SNDAGeneral
▼ -9.3%on this news

Sonida Senior Living Completes $1.8 Billion Strategic Merger with CNL Healthcare Properties, Inc.

Sonida Senior Living has successfully completed its $1.8 billion merger with CNL Healthcare Properties, creating a combined entity valued at $3.3 billion. This merger establishes Sonida as the eighth largest owner of senior living assets in the U.S., with approximately 14,700 owned units across various states. The merger is expected to generate significant synergies and improve the company's financial performance, including a projected 62% increase in normalized funds from operations per share. The integration includes additional talent from CNL's advisory team and aims to enhance operational efficiencies across its properties.

Read more →
-SNDA
Nov 10, 2025
SNDAGeneral

Sonida Senior Living Announces Third Quarter 2025 Results

Sonida Senior Living, Inc. reported its third-quarter results for 2025, indicating a strong year-on-year growth in revenue and occupancy rates. The company achieved a 21% increase in total portfolio community NOI and reported its highest same-store occupancy levels post-Covid at 87.7%. However, the net loss attributable to shareholders increased to $26.9 million from the previous year. The company also announced a significant merger with CNL Healthcare Properties that is expected to close in early 2026 and provide substantial value to shareholders.

Read more →
-SNDA
Nov 5, 2025
SNDAGeneral
▲ +14.7%on this news· ran to +25% by day 3shared move

Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction

Sonida Senior Living has announced a strategic merger with CNL Healthcare Properties, Inc. in a transaction valued at approximately $1.8 billion. The merger will create a combined entity valued around $3 billion, bolstering Sonida’s status as a significant player in the senior housing market. Both companies aim to improve operational efficiency and access more attractive market opportunities following the merger. The deal is set to close in early 2026, pending approval from shareholders of both companies.

Read more →
-SNDA
Aug 11, 2025
SNDAGeneral

Sonida Senior Living Announces Second Quarter 2025 Results

Sonida Senior Living, Inc. reported its second-quarter results for 2025, highlighting a 29.7% increase in resident revenue compared to the same period in 2024. The company achieved a net operating income of $16.7 million and improved its overall occupancy rates. However, Sonida still faced a net loss of $1.6 million, although this was a significant improvement from the previous year's loss. Additionally, the company is advancing its growth strategy with two new acquisitions in the Atlanta and Tampa markets, and it has secured a substantial loan to support further expansion.

Read more →
-SNDA
Jun 9, 2025
SNDAGeneral

Sonida Closes Two Previously Announced Senior Living Asset Acquisitions

Sonida Senior Living, Inc. has closed two acquisitions of senior living communities in Atlanta and Tampa for a total of $22 million. The communities were purchased at significant discounts to replacement costs, aligning with the Company’s focus on inorganic growth and regional densification. With this strategy, Sonida aims to enhance operating efficiency and capitalize on favorable demographics. Both acquisitions are expected to stabilize with a double-digit capitalization rate upon reaching maturity, reflecting the Company's positive outlook.

Read more →
-SNDA
May 12, 2025
SNDAGeneral
▲ +9.8%on this newsshared move

Sonida Senior Living Announces First Quarter 2025 Results

Sonida Senior Living, Inc. announced its Q1 2025 results, showcasing substantial revenue growth with a 30.6% increase in resident revenue year-over-year. The company reported a net loss of $12.5 million, contrasting with a profit of $27 million in the same period last year, largely due to a previous gain on extinguishment of debt. Meanwhile, Adjusted EBITDA increased by 43.2%, indicating improved operational efficiencies and financial health. Sonida is actively pursuing acquisition opportunities, highlighting a strategic focus on growth in both established and new markets.

Read more →
-SNDA
Mar 17, 2025
SNDAGeneral

Sonida Senior Living, Inc. Announces Fourth Quarter and Full Year 2024 Results

Sonida Senior Living, Inc. reported a transformative year for 2024, highlighted by robust growth and improved financial metrics. The company achieved a net loss reduction to $2.1 million and strong growth in both revenue and net operating income. Key results indicate a solid increase in occupancy rates and revenue metrics, driven by strategic acquisitions and operational enhancements. Additionally, Sonida secured a new credit facility to support further growth initiatives.

Read more →
-SNDA
Jan 6, 2025
SNDAGeneral

Sonida Announces Latest Asset Acquisition and Closing of Fannie Mae Maturity Modifications

Sonida Senior Living, Inc. has acquired a senior living community in Cincinnati, Ohio for $16.3 million, expanding its portfolio to 20 properties in 2024. This acquisition emphasizes their strategy of leveraging existing assets and extending their operational capacity. Alongside this, Sonida has completed a Fannie Mae loan modification that extends the maturity dates on $220 million of mortgage loans to January 2029, which will help ensure financial stability. However, the company faces challenges such as competition for labor and the potential difficulties in executing integration strategies.

Read more →
-SNDA
Nov 13, 2024
SNDAGeneral
▼ -5.3%on this newsshared move

Sonida Senior Living Announces Third Quarter 2024 Results DALLAS, Te xas - November 13, 20 24 - Sonid a Senior Living, Inc. (the "Company," "Sonida," "we," "our," or "us") (NYSE SNDA) a leading owner, operator and invest

Sonida Senior Living, Inc. reported its third quarter results for 2024, highlighting significant growth in revenue and occupancy. The company saw a 6.6% year-over-year increase in same-store resident revenue and expanded its portfolio by acquiring 19 senior living communities. Despite a reported net loss of $13.8 million, there was a notable improvement compared to the previous year, and Adjusted EBITDA rose by 8.7%. The results reflect a focus on operational and financial strategies aimed at enhancing performance and initiating further growth.

Read more →
-SNDA
Oct 28, 2024
SNDAGeneral
▲ +7.6%on this news

Sonida Announces General Counsel Transition

Sonida Senior Living, Inc. announced the appointment of Tabitha Bailey as the new general counsel, effective January 1, 2025, succeeding David Brickman. In his role for over 32 years, Brickman will support the transition through a consulting agreement while Bailey takes charge of the company's legal matters. Bailey brings substantial experience from her previous roles, including a recent position at Avantax, and is expected to drive the company's growth strategy. This leadership change aims to strengthen Sonida's legal functions and support its expansion goals.

Read more →
-SNDA
Oct 3, 2024
SNDAGeneral

Sonida Continues to Execute on its Accretive Growth Plan and Upsizes its Revolver Completes previously announced acquisition of eight senior living communities in the Southeast for $103 million, bringing total year-to-da

Sonida Senior Living, Inc. has executed a successful acquisition of eight senior living communities in the Southeast for $103 million, bringing its total acquisitions this year to 17 properties. The company has also signed an agreement for two additional communities in Atlanta for $29 million. Alongside this growth, Sonida has expanded its senior secured revolving credit facility to $150 million, providing significant capital for future investments. The acquisitions are anticipated to enhance Sonida's portfolio and align with its growth strategy in favorable markets.

Read more →

About Sonida Senior Living, Inc.

Dallas, TX 5,140 employees sonidaseniorliving.com
Headquarters14755 PRESTON ROAD, DALLAS, TX, 75254
BIOPHARMAWATCH ELITE PLUS
Trade the next SNDA catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime